EDSA (Edesa Biotech) Total Assets: $12.39 Mil (As of Mar. 2026)

What is Edesa Biotech Total Assets?

Edesa Biotech EDSA -3.23% 26 Total Assets is $12.39 Mil as of Mar. 2026. GuruFocus rates EDSA with a GF Score™ of 26/100. The stock has 2 warning signs investors should review.

Edesa Biotech's Total Assets for the quarter that ended in Mar. 2026 was $12.39 Mil.

During the past 12 months, Edesa Biotech's average Total Assets Growth Rate was -6.90% per year. During the past 3 years, the average Total Assets Growth Rate was -15.20% per year. During the past 5 years, the average Total Assets Growth Rate was -11.30% per year. During the past 10 years, the average Total Assets Growth Rate was 13.10% per year.

During the past 13 years, Edesa Biotech's highest 3-Year average Total Assets Growth Rate was 466.40%. The lowest was -25.60%. And the median was 25.20%.

Total Assets is connected with ROA %. Edesa Biotech's annualized ROA % for the quarter that ended in Mar. 2026 was -124.54%. Total Assets is also linked to Revenue through Asset Turnover. Edesa Biotech's Asset Turnover for the quarter that ended in Mar. 2026 was 0.00.

Edesa Biotech (NAS:EDSA) Total Assets Explanation

Total Assets is connected with ROA %.

Edesa Biotech's annualized ROA % for the quarter that ended in Mar. 2026 is

ROA %	=	Net Income (Q: Mar. 2026 )	/	( (Total Assets (Q: Dec. 2025 )	+	Total Assets (Q: Mar. 2026 ))	/ count )
	=	-16.872	/	( (14.71	+	12.385)	/ 2 )
	=	-16.872	/	13.5475
	=	-124.54 %

Note: The Net Income data used here is four times the quarterly (Mar. 2026) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Edesa Biotech's Asset Turnover for the quarter that ended in Mar. 2026 is

	Asset Turnover
=	Revenue (Q: Mar. 2026 )	/	( (Total Assets (Q: Dec. 2025 )	+	Total Assets (Q: Mar. 2026 ))	/ count )
=	0	/	( (14.71	+	12.385)	/ 2 )
=	0	/	13.5475
=	0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Edesa Biotech Total Assets Related Terms

Edesa Biotech Total Assets Historical Data

* Premium members only.

The historical data trend for Edesa Biotech's Total Assets can be seen below:

Edesa Biotech Total Assets Chart

Edesa Biotech Annual Data

Trend

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

Sep25

Total Assets

Get a 7-Day Free Trial

14.59

11.58

8.89

3.81

13.53

Edesa Biotech Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Total Assets	Get a 7-Day Free Trial															16.45	14.81	13.53	14.71	12.39

26GF Score

Edesa Biotech Inc EDSA

Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Edesa Biotech Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Edesa Biotech's Total Assets for the fiscal year that ended in Sep. 2025 is calculated as

Total Assets	=	Total Equity (A: Sep. 2025 )	+	Total Liabilities (A: Sep. 2025 )
	=	12.452	+	1.079
	=	13.53

Edesa Biotech's Total Assets for the quarter that ended in Mar. 2026 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2026 )	+	Total Liabilities (Q: Mar. 2026 )
	=	10.197	+	2.188
	=	12.39

Frequently Asked Questions Learn more about Total Assets →

What does a Total Assets of $12.39 Mil mean?

Edesa Biotech (EDSA) has a Total Assets of $12.39 Mil as of Mar. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on Edesa Biotech and its competitors.

Is Edesa Biotech's Total Assets too high?

Edesa Biotech's current Total Assets is $12.39 Mil. Overall, Edesa Biotech has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.

How does Edesa Biotech's Total Assets compare to ACET and HRTX?

Edesa Biotech's Total Assets of $12.39 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Total Assets for a Biotechnology company?

A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Total Assets mean?

A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Edesa Biotech and its competitors. Edesa Biotech's current Total Assets is $12.39 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Edesa Biotech stock overvalued right now?

Edesa Biotech (EDSA) has a current Total Assets of $12.39 Mil. The current Total Assets is $12.39 Mil. Edesa Biotech's overall GF Score™ is 26/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Total Assets calculated?

Total Assets is calculated from a company's financial statements. For Edesa Biotech (EDSA), the current Total Assets is $12.39 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Edesa Biotech Business Description

Industry Healthcare Biotechnology

Comparable Companies ACET HRTX ENTX GOSS OKYO ELTX RANI IBIO RNTX GANX VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Address 100 Spy Court, Markham, ON, CAN, L3R 5H6

Website https://www.edesabiotech.com

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

26GF Score

Get the complete analysis for EDSA

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.45

Price

View EDSA Analysis

See Total Assets data for all stocks →